Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Non-squamous Non-small Cell Lung Cancer × tusamitamab ravtansine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Non-small Cell Lung Cancer Metastatic 2 Stomach Neoplasms 1 Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC) 1 Non-squamous Non-small Cell Lung Cancer 1 Lung Neoplasms 1 Breast Neoplasms 1 Breast Cancer Metastatic 1 Adenocarcinoma Gastric 1

Interventions

Pemetrexed 6 Carboplatin 5 Bevacizumab 4 pembrolizumab 3 Cisplatin 3 anlotinib 2 Platinum 2 Paclitaxel 2 tusamitamab ravtansine 1 ixabepilone 1 icotinib 1 camrelizumab 1 Gefitinib 1 Erlotinib Hydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05245071 2025-08-29

CARMEN-LC06

Sanofi

Phase 2 Terminated

22 enrolled 11 charts

Non-squamous Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡